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Abstract We have studied the expression of XIAP, cIAP-1 and
cIAP-2 in fetal rat hepatocytes and its possible regulation by pro-
apoptotic stimuli (transforming growth factor-L (TGF-L)) and
survival signals (epidermal growth factor (EGF)). The three
forms of inhibitor of apoptosis proteins (IAPs) are expressed in
fetal hepatocytes and only cIAP-1, but not XIAP or cIAP-2, is
cleaved during TGF-L-induced apoptosis. The pan-caspase
inhibitor Z-VAD.fmk blocked this effect, which indicates that
cIAP-1 is a caspase substrate. EGF plays a dual role in the
regulation of IAPs expression. On one hand, it increases cIAP-1
and cIAP-2 basal expression and, on the other hand, it blocks the
cleavage of cIAP-1 by caspases induced by TGF-L. , 2002
Published by Elsevier Science B.V. on behalf of the Federation
of European Biochemical Societies.
Key words: Inhibitor of apoptosis protein; Hepatocyte;
Transforming growth factor-L ; Epidermal growth factor;
Apoptosis
1. Introduction
Apoptosis has evolved as a physiological cell death in re-
sponse to environmental and developmental signals, with the
mitochondria playing an essential role. The key to under-
standing apoptosis is the activation and function of a set of
proteinases, the caspases (cysteine proteases with speci¢city
for aspartic residues) [1^3]. The functions of caspases are
modulated by another set of proteins, the IAPs (inhibitor of
apoptosis proteins) [2^5]. The IAP family of proteins are char-
acterized by a novel domain of 70 amino acids termed the
baculoviral IAP repeat, the name of which derives from the
original discovery of these apoptosis suppressors in the bacu-
loviruses [6,7]. Although the estructural requirements for IAP
function may vary, numerous reports strongly suggest that at
least some IAP family members play a conserved role in the
regulation of cell death. Consistent with this, the human IAP
family members XIAP, cIAP-1 and cIAP-2 can directly inhibit
speci¢c caspases [8,9]. XIAP appears to be widely expressed
[10], whereas cIAP-1 and cIAP-2 expression is increased fol-
lowing activation of the NFUB transcription factor [11].
Although evidence for a direct oncogenic role for the IAPs
has to be delineated, a number of evidences point towards this
class of proteins playing a role in oncogenesis [12].
Apoptotic stimuli must impair the IAPs ability to suppress
the caspase cascade. In this context, it has been described that,
during the apoptosis induced by Fas, XIAP is cleaved into
two fragments, which have a signi¢cantly reduced anti-apo-
ptotic e⁄ciency compared with full-length XIAP [13]. Thus,
cleavage of XIAP may be one mechanism by which cell death
programs circumvent the anti-apoptotic barrier posed by
XIAP. In this same line of evidence, cIAP-1 is cleaved by
caspases to produce a pro-apoptotic C-terminal fragment [14].
Numerous observations suggest that transforming growth
factor-L (TGF-L), an extracellular polypeptide important in
growth control, development and di¡erentiation [15], plays
an important biological role mediating hepatocyte death
[16]. Previous work from our group showed that treatment
of fetal rat hepatocytes with TGF-L1 is followed by apoptosis
[17]. TGF-L1 mediates radical oxygen species (ROS) produc-
tion [17,18], that precedes the loss of v8m, and the release of
cytochrome c [19]. TGF-L disruption of the mitochondrial
transmembrane potential and release of cytochrome c are
blocked by epidermal growth factor (EGF) [19]. TGF-L1 ac-
tivates at least caspase-3, -8 and -9 in hepatocytes [20^22],
which are not required for ROS production, glutathione de-
pletion, Bcl-xL down-regulation and initial cytochrome c re-
lease [22]. However, caspase activation mediates cleavage of
Bid and Bcl-xL that originate an ampli¢cation loop on the
mitochondrial events [22].
The expression of IAPS in the liver and its possible regu-
lation by apoptotic stimuli, such as TGF-L, or survival sig-
nals, such as EGF, have not been explored yet. Only a report
from Shima et al. indicates that XIAP is expressed in human
hepatoma cells (HuH7) and it is down-regulated by TGF-L
[23]. According to this, the aim of this work was to study the
expression of XIAP, cIAP-1 and cIAP-2 in fetal rat primary
hepatocytes and its possible regulation by TGF-L and apopto-
sis inhibitors, such as EGF.
2. Materials and methods
2.1. Isolation of rat fetal hepatocytes and culture
Hepatocytes from 20-day-old fetal Wistar rats were isolated by
collagenase disruption [24], plated in arginine free medium 199, sup-
plemented with ornithine (200 Wmol/l), fetal calf serum (10%), peni-
cillin (120 Wg/ml) and streptomycin (100 Wg/ml) and incubated as
previously described [19].
2.2. Western blot analysis
Supernatant cells and attached cells (after being scraped o¡ in
phosphate-bu¡ered saline) were pelleted by centrifugation and resus-
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pended in a lysis bu¡er (25 mmol/l HEPES, pH 7.5, 0.3 mol/l NaCl;
1.5 mmol/l MgCl2, 0.2 mmol/l EDTA, 0.5 mmol/l dithiothreitol
(DTT), 0.1% Triton X-100; 20 mmol/l L-glycero-phosphate, 0.1
mmol/l Na3VO4, 2 Wg/ml leupeptin and 1 mmol/l phenylmethylsul-
fonyl £uoride) during 10 min at 4‡C. Then samples were clari¢ed
by centrifugation at 12 000Ug for 10 min at 4‡C. Anti-cIAP-1 and
anti-cIAP-2 polyclonal antibodies were from RpD Systems, anti-
XIAP monoclonal antibody was from Transduction Laboratories,
anti-L-actin monoclonal antibody was from Sigma.
2.3. Analysis of nuclear DNA content by £ow cytometry
The ploidy determination of hepatocytes was estimated by £ow
cytometry DNA analysis. Cells were detached by trypsinization, ¢xed
in methanol (320‡C) for 1 min and treated with RNase (10 Wg/ml) for
30 min at 37‡C. The DNA content per cell was then evaluated in a
FACScan £ow cytometer (Becton Dickinson, San Jose, CA, USA)
after staining cells with propidium iodide (0.05 mg/ml) for 15 min
at room temperature in the dark.
2.4. Analysis of caspase-3 activity
Cells were lysed as previously described [22]. Protein concentration
of cell lysates was determined by Bio-Rad protein assay kit. Reaction
mixtures contained 20 mmol/l HEPES pH 7.0, 10% glycerol, 2 mmol/l
DTT, 30 Wg protein/condition and 20 Wmol/l Ac-DEVD-AMC sub-
strate (Pharmingen). After 2 h of incubation in the dark, enzymatic
activity was measured in a Microplate Fluorescence Reader FL600
(Bio-Tek). A unit of caspase-3 activity is de¢ned as the amount of
active enzyme necessary to produce an increase of one arbitrary unit
in the luminescence spectrophotometer after 2 h.
3. Results and discussion
We have analyzed the presence of XIAP, cIAP-1 and cIAP-2
in fetal rat hepatocytes in primary culture. Under control
conditions the three members of the IAP family were clearly
expressed, cIAP-1 being the less abundant form (Fig. 1A). In
response to TGF-L, and in a dose-dependent manner, cIAP-1
protein levels decreased, without change in the XIAP and
cIAP-2 forms (Fig. 1A). Dose-dependence for cIAP-1 regula-
tion was coincident with the appearance of hypodiploid cells,
characteristic of an apoptotic process (Fig. 1B). A detailed
timing analysis demonstrated that cIAP-1 levels decreased
after 10 h of incubation in the presence of TGF-L. According
to previous results of our group [22], at that time cytochrome c
has been released from mitochondria and caspases must be
activated. Thus, as it is shown in Fig. 2B, activity of caspase-3
reached a maximum at 10 h of TGF-L treatment.
Since cIAP-1 expression is under control of NFUB [11] and
treatment of fetal hepatocytes with TGF-L produces NFUB
inactivation [25], cIAP-1 levels could be under transcriptional
control. However, taking into account that cIAP-1 is a cas-
pase substrate [14], regulation of cIAP-1 protein levels could
also be posttranslational. To solve this question, we incubated
fetal rat hepatocytes in the presence of a pan-inhibitor of
caspases: Z-VAD.fmk (Fig. 3). The result was very clear:
Fig. 1. E¡ect of TGF-L on IAPs family proteins in fetal rat hepato-
cytes. A: Dose response e¡ect of TGF-L on cIAP-1, cIAP-2 and
X-IAP protein levels (analyzed by Western blot), after incubation of
cells for 15 h with the di¡erent concentrations of TGF-L. A repre-
sentative experiment of three is shown. L-Actin is analyzed as load-
ing control. B: Dose response e¡ect of TGF-L on cIAP-1 protein
levels as compared with the analysis of apoptosis, i.e. the appear-
ance of hypodiploid cells. The densitometric analysis of cIAP-1 pro-
tein level (corrected by L-actin content and expressed as percentage
of untreated cells) of a representative experiment (n=3) is shown.
Parallel dishes in the same experiment were processed for analysis
of nuclear DNA content by £ow cytometry, to calculate the per-
centage of hypodiploid (apoptotic) cells. A representative experiment
of three is shown.
Fig. 2. Time course e¡ect of TGF-L on cIAP-1 protein levels in fe-
tal hepatocytes. A: Cells were incubated without (0) or with 2 ng/ml
of TGF-L for di¡erent periods of time. Then, proteins were ex-
tracted and cIAP-1 protein levels were analyzed by Western blot.
L-Actin is analyzed as loading control. A representative experiment
of four is shown. B: Time course analysis of caspase-3 activation.
Cells from parallel dishes in the experiment shown in A were lysed
and caspase-3 was assayed. Results are expressed as unitsU100/Wg
protein. A representative experiment of three is shown.
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under conditions where Z-VAD.fmk completely blocked cas-
pase-3 activity (Fig. 3A), the decrease in the cIAP-1 protein
levels was also completely abolished (Fig. 3B). A detailed
observation of the Western blot analysis revealed that under
treatment with TGF-L, cIAP-1 appeared to be cleaved, show-
ing a band of 35 kDa, which has been proposed to have pro-
apoptotic activity [14]. In the presence of Z-VAD.fmk, this
band completely disappeared (Fig. 3B). This is a clear dem-
onstration that cIAP-1 is a substrate of caspases during the
apoptosis induced by TGF-L in fetal hepatocytes. This event
might contribute to a caspase-mediated ampli¢cation loop on
the apoptotic events.
An intriguing result is that XIAP is not modulated by
TGF-L in fetal rat hepatocytes, i.e. XIAP levels remain intact
during the apoptosis induced by TGF-L. XIAP has been re-
ported as a cofactor in the TGF-L superfamily signaling
[26,27]. XIAP, but not the related proteins cIAP-1 and
cIAP-2, associates with several members of the type I class
of the TGF-L receptor and increases TGF-L-induced signaling
[27]. This role for XIAP in TGF-L-mediated signaling appears
to be distinct from and independent of its anti-apoptotic func-
tions. Thus, XIAP might be necessary for the response of fetal
hepatocytes to TGF-L.
The apoptosis induced by TGF-L in fetal hepatocytes is
impaired by EGF [28], via a PI 3-kinase-dependent pathway
[29]. Furthermore, EGF activates NFUB in fetal rat hepato-
cytes (Fabregat et al., unpublished observations). All these
data pointed towards EGF as a possible regulator of cIAP-1
expression and/or cleavage. Results presented in Fig. 4 show
that when fetal hepatocytes were incubated in the presence of
both TGF-L and EGF apoptosis was impaired (Fig. 4A), and
activation of caspase-3 notably attenuated (Fig. 4B). This im-
pairment of apoptosis was completely blocked in the presence
of LY294002, an inhibitor of PI 3-kinase activity. When we
studied the protein levels of IAPs, we observed that EGF by
itself was able to produce a signi¢cant increase in cIAP-1 and
cIAP-2 (Fig. 4C). In contrast, it had no signi¢cant e¡ect on
XIAP protein levels (results not shown). The increase in both
Fig. 3. cIAP-1 is cleaved by caspases during the apoptosis induced
by TGF-L in fetal hepatocytes. A: Fetal hepatocytes were incubated
in the absence or presence of TGF-L (2 ng/ml) or TGF-L (2 ng/
ml)+Z-VAD.fmk (20 Wmol/l, added 1 h before TGF-L) for 15 h.
After this time, cells were lysed and caspase-3 activity was assayed.
Results are expressed as unitsU100/Wg protein and are meanT
S.E.M. of three independent experiments with duplicate dishes.
B: Cells were incubated under the same conditions described in A.
Then, proteins were extracted and cIAP-1 protein levels were ana-
lyzed by Western blot. L-Actin content is analyzed as loading con-
trol. A representative experiment of three is shown.
Fig. 4. E¡ect of EGF on IAPs expression. Role of PI 3-kinase. Fe-
tal hepatocytes were incubated for 15 h in the absence (control cells)
or presence of 2 ng/ml TGF-L and/or EGF (20 ng/ml) and/or
LY294002 (a PI 3-kinase inhibitor used at 20 Wmol/l and added 1 h
before TGF-L and EGF), as indicated. A: Cells were detached by
trypsinization and cell DNA content was analyzed by £ow cytome-
try. Results are expressed as percentage of hypodiploid cells, and
are meanTS.E.M. of three independent experiments. B: Cells were
lysed and caspase-3 assayed. Results are expressed as unitsU100/Wg
protein, and are meanTS.E.M. of three independent experiments
with duplicate dishes. C: Cells were lysed to analyze cIAP-1 and
cIAP-2 protein levels by Western blot. In the case of cIAP-1, the
proteolytic fragment is also shown. L-Actin content is analyzed as
loading control. A representative experiment of three is shown.
Densitometric analysis of Western blots was used to calculate the
protein levels (corrected by L-actin content and expressed as per-
centage of untreated cells). MeansTS.E.M. of the three independent
experiments are shown.
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cIAPs was not blocked by the presence of LY294002, which
indicates that PI 3-kinase is not mediating this e¡ect. Further-
more, in the case of cIAP-1, EGF was also able to abolish the
loss of protein caused by TGF-L and the appearance of the
proteolytic fragment of 35 kDa (Fig. 4C), this e¡ect being
completely dependent on PI 3-kinase. These results indicate
that EGF plays a dual role on the regulation of IAPs. Firstly,
this growth factor increases the basal levels of cIAP-1 and
cIAP-2, the two members of the family that are under tran-
scriptional control by NFUB [11]. Secondly, PI 3-kinase acti-
vation by EGF is responsible for the maintenance of cIAP-1
levels, even when TGF-L is present, probably through its abil-
ity to block caspase activation (Fig. 4B).
In conclusion, we describe that fetal rat hepatocytes express
cIAP-1, cIAP-2 and XIAP and only cIAP-1, but not XIAP or
cIAP-2, is substrate of caspases during the apoptosis induced
by TGF-L. EGF plays a dual role in the regulation of these
IAPs expression. On one hand, it blocks the cleavage of cIAP-
1 by caspases and, on the other hand, it increases cIAP-1 and
cIAP-2 basal expression. It is worthy to note that the less
abundant form, cIAP-1, and one of the less e¡ective in inhib-
iting caspases [30], is the form that is proteolysed by TGF-L.
Probably this event can form part of an ampli¢cation loop
initiated by caspases where cIAP-1 is transformed into a pro-
apoptotic form [14]. In this same line of evidence, we have
recently described that also Bcl-xL and Bid are substrates of
the caspases activated by TGF-L [22]. The absence of XIAP
modulation could indicate that XIAP is essential for the TGF-
L signaling, as has previously been suggested [26,27]. How-
ever, taking into account its high expression, other cellular
events initiated by TGF-L must inactivate its anti-apoptotic
activity. Future e¡orts must be done to clarify the possible
appearance in the cytosol of some inhibitors of XIAP, such as
DIABLO/Smac [31] or XAF1 [32], which can contribute to
the activation of caspases by TGF-L.
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